Literature DB >> 12526011

Liquid chromatographic/tandem mass spectrometric method for the determination of the tobacco-specific nitrosamine metabolite NNAL in smokers' urine.

Gary D Byrd1, Michael W Ogden.   

Abstract

A specific and rapid liquid chromatographic/tandem mass spectrometric (LC/MS/MS) method was developed and validated for NNAL, a metabolite of the tobacco-specific nitrosamine metabolite NNK. The metabolite was detected in smokers' urine with a limit of quantitation (LOQ) of 20 pg ml(-1) and a linear range up to 1000 pg ml(-1). The method features a single solid-phase extraction step and MS/MS monitoring following electrospray ionization. Fragmentation pathways for the protonated molecular ion are proposed. The sample preparation is simpler than that for gas chromatographic methods reported in the literature and maintains sensitivity adequate for determining NNAL in smokers' urine. By using enzyme hydrolysis to determine total NNAL in urine, the amount of NNAL-glucuronide was calculated. A standard pooled smokers' urine sample used for development gave values of 176 +/- 8 pg ml(-1) free NNAL and 675 +/- 26 pg ml(-1) total NNAL following enzyme hydrolysis. The method was applied to a group of seven smokers; the free NNAL level for the group was 101-256 pg ml(-1) with NNAL-glucuronides at 247-566 pg ml(-1). The ratio of conjugated to free NNAL was in the range 0.98-2.95. The variability in total daily amount of NNAL excreted (ng per 24 h) had RSDs of 6-21% for free NNAL, 7-22% for conjugated NNAL and 6-20% for total NNAL excreted. When normalized to the number of cigarettes smoked, the amounts of NNAL excreted per cigarette smoked were in the range of amounts of NNK yields reported for cigarettes in the literature. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12526011     DOI: 10.1002/jms.406

Source DB:  PubMed          Journal:  J Mass Spectrom        ISSN: 1076-5174            Impact factor:   1.982


  10 in total

Review 1.  Biomarkers to assess the utility of potential reduced exposure tobacco products.

Authors:  Dorothy K Hatsukami; Neal L Benowitz; Stephen I Rennard; Cheryl Oncken; Stephen S Hecht
Journal:  Nicotine Tob Res       Date:  2006-08       Impact factor: 4.244

2.  A LC-MS/MS method for concurrent determination of nicotine metabolites and role of CYP2A6 in nicotine metabolism in U937 macrophages: implications in oxidative stress in HIV + smokers.

Authors:  Mengyao Jin; Ravinder Earla; Ankit Shah; Rajya L Earla; Raeesa Gupte; Ashim K Mitra; Anil Kumar; Santosh Kumar
Journal:  J Neuroimmune Pharmacol       Date:  2011-06-08       Impact factor: 4.147

3.  High throughput liquid and gas chromatography-tandem mass spectrometry assays for tobacco-specific nitrosamine and polycyclic aromatic hydrocarbon metabolites associated with lung cancer in smokers.

Authors:  Steven G Carmella; Xun Ming; Natalie Olvera; Claire Brookmeyer; Andrea Yoder; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2013-07-24       Impact factor: 3.739

4.  A new liquid chromatography/mass spectrometry method for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine.

Authors:  Showket H Bhat; Stacy L Gelhaus; Clementina Mesaros; Anil Vachani; Ian A Blair
Journal:  Rapid Commun Mass Spectrom       Date:  2011-01-15       Impact factor: 2.419

5.  An LC-MS/MS method for concurrent determination of nicotine metabolites and the role of CYP2A6 in nicotine metabolite-mediated oxidative stress in SVGA astrocytes.

Authors:  Anusha Ande; Ravinder Earla; Mengyao Jin; Peter S Silverstein; Ashim K Mitra; Anil Kumar; Santosh Kumar
Journal:  Drug Alcohol Depend       Date:  2012-04-11       Impact factor: 4.492

Review 6.  High-performance liquid chromatography-tandem mass spectrometry in the identification and determination of phase I and phase II drug metabolites.

Authors:  M Holcapek; L Kolárová; M Nobilis
Journal:  Anal Bioanal Chem       Date:  2008-03-15       Impact factor: 4.142

7.  Subpicogram per milliliter determination of the tobacco-specific carcinogen metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chromatography-tandem mass spectrometry.

Authors:  Peyton Jacob; Christopher Havel; Do-Hoon Lee; Lisa Yu; Mark D Eisner; Neal L Benowitz
Journal:  Anal Chem       Date:  2008-10-08       Impact factor: 6.986

8.  Study of cardiovascular disease biomarkers among tobacco consumers, part 1: biomarkers of exposure.

Authors:  Leanne R Campbell; Buddy G Brown; Bobbette A Jones; Kristin M Marano; Michael F Borgerding
Journal:  Inhal Toxicol       Date:  2015-03-19       Impact factor: 2.724

Review 9.  Understanding Metabolomics in Biomedical Research.

Authors:  Su Jung Kim; Su Hee Kim; Ji Hyun Kim; Shin Hwang; Hyun Ju Yoo
Journal:  Endocrinol Metab (Seoul)       Date:  2016-03

10.  Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: Part 2. Biomarkers of exposure.

Authors:  Michael W Ogden; Kristin M Marano; Bobbette A Jones; Walter T Morgan; Mitchell F Stiles
Journal:  Biomarkers       Date:  2015-11-10       Impact factor: 2.658

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.